Vertex Pharmaceuticals presented updates at a Wells Fargo conference on September 12, 2026.
1 report, 1 independent
Updated Sep 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vertex Pharmaceuticals presented updates at a Wells Fargo conference on September 12, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vertex Pharmaceuticals
American pharmaceutical company
-
Wells Fargo
American multinational banking and financial services company
Related events
- Goldman Sachs updated its top stock picks, removing Interactive Brokers and adding Vertex Pharmaceuticals.
- Biogen executives spoke at a conference hosted by Wells Fargo on September 12, 2026.
- Vertex Pharmaceuticals trades on Nasdaq, files reports with the SEC, and has an executive named Duncan McKechnie.
- Morgan Stanley began research coverage on Vertex Pharmaceuticals, raising its target price and giving it an overweight rating, alongside institutional filings.
- Vertex Pharmaceuticals had required 13F filings with the SEC and its stock traded on the Nasdaq exchange on September 8, 2026.